Search research articles
Contact Us
Filters
Showing results (251-260 of 652) with videos related to
Page
of 66
Sort By:
AJR. American Journal of Roentgenology
|
October 1, 1991
The value of barium as a gastrointestinal contrast agent in MR imaging: a comparison study in normal volunteers
P R Ros, R M Steinman, G M Torres, et al.
The Review of Scientific Instruments
|
February 20, 2026
Integrated setup for time and spatially resolved micro-photoluminescence
M Perlangeli, G M Pierantozzi, A Fondacaro, et al.
Journal of the Canadian Association of Gastroenterology
|
February 11, 2026
Communicating Needs and Features of IBD Experiences study: Canadian individuals and healthcare professional perceptions of the experience and impact of symptoms of moderate-to-severe ulcerative colitis and Crohn's disease
Vipul Jairath, Talat Bessissow, Jennifer Glass, et al.
Nano Letters
|
December 15, 2023
Directionally-Resolved Phononic Properties of Monolayer 2D Molybdenum Ditelluride (MoTe<sub>2</sub>) under Uniaxial Elastic Strain
Zhewen Yin, Wyatt Panaccione, Anjun Hu, et al.
Inflammatory Bowel Diseases
|
November 25, 2011
Antibodies to mutated citrullinated vimentin and anti-cyclic citrullinated peptide antibodies in inflammatory bowel disease and related arthritis
Khaled Al-Jarallah, Diaa Shehab, Rajaa Al-Attiyah, et al.
Nature Reviews. Disease Primers
|
May 21, 2020
Author Correction: Crohn's disease
Giulia Roda, Siew Chien Ng, Paulo Gustavo Kotze, et al.
Nature Reviews. Disease Primers
|
June 21, 2020
Author Correction: Crohn's disease
Giulia Roda, Siew Chien Ng, Paulo Gustavo Kotze, et al.
Gastroenterology
|
February 14, 2006
Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial
Stephen B Hanauer, William J Sandborn, Paul Rutgeerts, et al.
Alimentary Pharmacology & Therapeutics
|
October 19, 2013
Adalimumab maintains remission of Crohn's disease after up to 4 years of treatment: data from CHARM and ADHERE
R Panaccione, J-F Colombel, W J Sandborn, et al.
Inflammatory Bowel Diseases
|
November 24, 2015
Immunogenicity of Influenza Vaccine for Patients with Inflammatory Bowel Disease on Maintenance Infliximab Therapy: A Randomized Trial
Jennifer deBruyn, Kevin Fonseca, Subrata Ghosh, et al.
Page
of 66
Search research articles
Search
Showing results (251-260 of 652) with videos related to
Sort By:
Page
of 66
AJR. American Journal of Roentgenology
|
October 1, 1991
The value of barium as a gastrointestinal contrast agent in MR imaging: a comparison study in normal volunteers
P R Ros, R M Steinman, G M Torres, et al.
The Review of Scientific Instruments
|
February 20, 2026
Integrated setup for time and spatially resolved micro-photoluminescence
M Perlangeli, G M Pierantozzi, A Fondacaro, et al.
Journal of the Canadian Association of Gastroenterology
|
February 11, 2026
Communicating Needs and Features of IBD Experiences study: Canadian individuals and healthcare professional perceptions of the experience and impact of symptoms of moderate-to-severe ulcerative colitis and Crohn's disease
Vipul Jairath, Talat Bessissow, Jennifer Glass, et al.
Nano Letters
|
December 15, 2023
Directionally-Resolved Phononic Properties of Monolayer 2D Molybdenum Ditelluride (MoTe<sub>2</sub>) under Uniaxial Elastic Strain
Zhewen Yin, Wyatt Panaccione, Anjun Hu, et al.
Inflammatory Bowel Diseases
|
November 25, 2011
Antibodies to mutated citrullinated vimentin and anti-cyclic citrullinated peptide antibodies in inflammatory bowel disease and related arthritis
Khaled Al-Jarallah, Diaa Shehab, Rajaa Al-Attiyah, et al.
Nature Reviews. Disease Primers
|
May 21, 2020
Author Correction: Crohn's disease
Giulia Roda, Siew Chien Ng, Paulo Gustavo Kotze, et al.
Nature Reviews. Disease Primers
|
June 21, 2020
Author Correction: Crohn's disease
Giulia Roda, Siew Chien Ng, Paulo Gustavo Kotze, et al.
Gastroenterology
|
February 14, 2006
Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial
Stephen B Hanauer, William J Sandborn, Paul Rutgeerts, et al.
Alimentary Pharmacology & Therapeutics
|
October 19, 2013
Adalimumab maintains remission of Crohn's disease after up to 4 years of treatment: data from CHARM and ADHERE
R Panaccione, J-F Colombel, W J Sandborn, et al.
Inflammatory Bowel Diseases
|
November 24, 2015
Immunogenicity of Influenza Vaccine for Patients with Inflammatory Bowel Disease on Maintenance Infliximab Therapy: A Randomized Trial
Jennifer deBruyn, Kevin Fonseca, Subrata Ghosh, et al.
Page
of 66